Nanjing Pharmaceutical Group Company Limited (SHA:600713)
5.00
+0.06 (1.21%)
Sep 30, 2026, 3:00 PM CST
| Market Cap | 6.54B +0.7% |
| Revenue (ttm) | 54.82B +0.7% |
| Net Income | 628.03M +14.1% |
| EPS | 0.43 +6.6% |
| Shares Out | 1.31B |
| PE Ratio | 11.74 |
| Forward PE | n/a |
| Dividend | 0.18 (3.60%) |
| Ex-Dividend Date | Sep 17, 2026 |
| Volume | 6,798,939 |
| Open | 4.95 |
| Previous Close | 4.94 |
| Day's Range | 4.93 - 5.02 |
| 52-Week Range | 4.81 - 6.65 |
| Beta | 0.20 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 31, 2026 |